DRUG UTILIZATION STUDY OF ANTIHYPERGLYCEMIC AGENTS IN OUTPATIENTS AT OPD CLINICS IN SOUTH INDIAN METROPOLITAN CITY
Abstract
Objective: To determine the drug utilization pattern of anti-diabetic medications in diabetic patients at diabetic outpatient clinics.
Methods: A prospective observational study was conducted to find out the drugs utilization and prescriptions pattern of antihyperglycemic agents in diabetic outpatients in urban Telangana. This study was conducted for a period of six months, known cases of Diabetic Mellitus who were receiving antihyperglycemic medicines as outpatients of either sex of all age groups were included and Patients with gestational diabetes were excluded from the study.
Results: In this study a total number of 250 prescriptions were collected which contained 1674 drugs. Among the prescriptions as an average each prescription contained more than 6.7drugs, this indicates polypharmacy. Among the antidiabetic drugs, metformin was found in a maximum number of prescription i.e. 109 (43.60%) and sitagliptin was found in a minimum number of prescriptions i.e.28 (11.20%) and most of the prescriptions contained antihypertensive agents, analgesics, vitamins and minerals preparations as supplements.
Conclusion: This report alarm all the physicians and health care professionals about various drug interactions and adverse drug reactions which occur due to polypharmacy and also causing a more financial burden to chronic disease patients.
Keywords: Drug utilization, Diabetes, Drug-drug interactions, Adverse drug reactions, DDD-defined daily dosage, ATC-Anatomical Therapeutic Chemical Classification and OPD-outpatient department
Downloads
References
REFERENCES
About diabetes. World Health Organization. Retrieved 4 April 2014.
Diabetes Fact sheet N°312. WHO. October 2013. Retrieved25 March 2014.
Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care Jul 2009; 32 (7): 1335–43.
IDF DIABETES ATLAS. 6th ed. International Diabetes Federation. 2013; 7.
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet Dec 2015; 2012380 (9859): 2163–96.
Cooke DW, Plotnick L. Type 1 diabetes mellitus in pediatrics. Pediatric Rev Nov 2008; 29 (11): 374–84.
IDF. International Diabetes Federation. Retrieved 29 Nov 2014.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27 (5): 1047–53.
World Health Organization (WHO) and International Network for Rational Use of Drugs, How to Investigate Drug Use in Health Facilities: Selected Drug Use indicators, WHO/DAP/93.1,WHO, Geneva, Switzerland, 1993.
World Health Organization (WHO) International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services, Introduction to Drug Utilization Research, WHO, Oslo, Norway, 2003.
World Health Organization, Introduction to Drug Utilization Research, WHO, Oslo, Norway, 2003.
D Lee, U Bergman, L. B. Storm, Ed .John Wiley & Sons, Chichester, UK. Studies of drug utilization in Pharmacoepidemiology 2005; 401–417.
N Y Mirza, S Desai, and B Ganguly. Prescribing pattern in a pediatric out-patient department in Gujarat. Bangladesh Journal of Pharmacology 2009; 4(1):39–42.
H V Hogerzeil. Promoting rational prescribing: an international perspective. British Journal of Clinical Pharmacology 1995; 39(1):1–6.
B Dineshkumar, T. C. Raghuram, G. Radhaiah, and K. Krishnaswamy. Profile of drug use in urban and rural India. PharmacoEconomics 1995; 7(4):332–346.
R Likic, I Francetic, M Bilusic et al. Benefits of optimization in antibiotic use. Collegium Antropologicum 2007; 31(1):241-246.
World Health Organization (WHO) and International Network for Rational Use of Drugs, How to Investigate Drug Use in Health Facilities: Selected Drug Use indicators, WHO/DAP/93.1. WHO, Geneva, Switzerland, 1993.
World health organization (WHO) international working group for drug statistics methodology, who collaborating centre for drug statistics methodology, who collaborating centre for drug utilization research and clinical pharmacological services, introduction to drug utilization research, WHO, oslo, norway, 2003.
World Health Organization, Introduction to Drug Utilization Research, WHO, Oslo, Norway, 2003.
Ruckmani A. Rational drug use: A remote possibility? Bulletin on Drug and Health Information 1995; 2(1):20.
M Nehru, K Kohli, B Kapoor, P Sadhotra, V Chopra, and R Sharma. Drug utilization study in outpatient ophthalmology department of Government Medical College Jammu. JK Science 2005;7(3):149–151.
WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs. Oslo: WHO Collaborating Centre for Drug Statistics Methodology 2002.